Windlas Biotech Limited (WINDLAS.BO)
INR 924.95
(-0.21%)
INR 924.95
(-0.21%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1 Billion INR | -49.6% |
| 2022 | 1.37 Billion INR | 14.37% |
| 2021 | 1.19 Billion INR | 11.1% |
| 2020 | 1.07 Billion INR | 28.07% |
| 2019 | 843.15 Million INR | 1.55% |
| 2018 | 830.32 Million INR | 299.0% |
| 2017 | 208.1 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 170.18 Million INR | -11.72% |
| 2023 Q2 | 414.4 Million INR | 5.37% |
| 2023 Q3 | 436.22 Million INR | 5.27% |
| 2023 FY | 691.52 Million INR | -49.6% |
| 2023 Q1 | 393.29 Million INR | 8.04% |
| 2023 Q4 | 192.77 Million INR | -55.81% |
| 2022 Q2 | 351.81 Million INR | 8.38% |
| 2022 FY | 1.37 Billion INR | 14.37% |
| 2022 Q4 | 364.02 Million INR | 9.76% |
| 2022 Q3 | 331.65 Million INR | -5.73% |
| 2022 Q1 | 324.62 Million INR | 12.5% |
| 2021 Q4 | 288.55 Million INR | -6.09% |
| 2021 FY | 1.19 Billion INR | 11.1% |
| 2021 Q3 | 307.27 Million INR | 2.08% |
| 2021 Q2 | 301.02 Million INR | -0.6% |
| 2021 Q1 | 302.84 Million INR | 23.56% |
| 2020 Q4 | 245.09 Million INR | -18.42% |
| 2020 Q3 | 300.43 Million INR | 6.93% |
| 2020 Q1 | 464.3 Million INR | 100.66% |
| 2020 Q2 | 280.96 Million INR | -39.49% |
| 2020 FY | 1.07 Billion INR | 28.07% |
| 2019 FY | 843.15 Million INR | 1.55% |
| 2019 Q4 | 231.39 Million INR | 0.0% |
| 2018 FY | 830.32 Million INR | 299.0% |
| 2017 FY | 208.1 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 93.658% |
| Aurobindo Pharma Limited | 39.23 Billion INR | 97.435% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 91.354% |
| Granules India Limited | 7.18 Billion INR | 85.986% |
| Indoco Remedies Limited | 4.74 Billion INR | 78.805% |
| Achyut Healthcare Limited | 1.6 Million INR | -62455.003% |
| Ajanta Pharma Limited | 30.46 Billion INR | 96.696% |
| Alkem Laboratories Limited | 32.83 Billion INR | 96.935% |
| Alpa Laboratories Limited | 156.14 Million INR | -544.591% |
| Brooks Laboratories Limited | 51.18 Million INR | -1866.608% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | 61.294% |
| Bajaj HealthCare Limited | 985.34 Million INR | -2.148% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | 29.08% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.95% |
| Eris Lifesciences Limited | 4.94 Billion INR | 79.637% |
| FDC Limited | 5.34 Billion INR | 81.182% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 98.51% |
| Gufic Biosciences Limited | 1.07 Billion INR | 6.607% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | 52.617% |
| Ipca Laboratories Limited | 13.91 Billion INR | 92.767% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -30.139% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -2080.67% |
| Lasa Supergenerics Limited | 291.17 Million INR | -245.673% |
| Laurus Labs Limited | 3.01 Billion INR | 66.57% |
| Lupin Limited | 95.67 Billion INR | 98.948% |
| Mankind Pharma Limited | 23.15 Billion INR | 95.653% |
| Medicamen Biotech Limited | 335.16 Million INR | -200.301% |
| Medico Remedies Limited | 161.84 Million INR | -521.901% |
| Megasoft Limited | 49.52 Million INR | -1932.204% |
| NATCO Pharma Limited | 10.05 Billion INR | 89.993% |
| Piramal Pharma Limited | 19.91 Billion INR | 94.946% |
| RPG Life Sciences Limited | 1.63 Billion INR | 38.459% |
| Sigachi Industries Limited | 579.88 Million INR | -73.57% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.347% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | 28.249% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -6.803% |
| Unichem Laboratories Limited | 6.72 Billion INR | 85.035% |
| Wanbury Limited | 1.16 Billion INR | 13.301% |
| ZIM Laboratories Limited | 1.01 Billion INR | 0.646% |
| Zydus Lifesciences Limited | 43.17 Billion INR | 97.669% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 67.287% |
| Divi's Laboratories Limited | 14.17 Billion INR | 92.897% |
| Hester Biosciences Limited | 908.84 Million INR | -10.747% |
| Procter & Gamble Health Limited | 2.99 Billion INR | 66.398% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | 8.415% |
| Bal Pharma Limited | 389.89 Million INR | -158.152% |
| Strides Pharma Science Limited | 9.16 Billion INR | 89.015% |
| Venus Remedies Limited | 1.91 Billion INR | 47.476% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | 67.262% |
| Nectar Lifesciences Limited | 625.55 Million INR | -60.9% |
| Shilpa Medicare Limited | 2.18 Billion INR | 53.842% |
| Aarti Drugs Limited | 1.16 Billion INR | 13.788% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | 8.399% |
| Suven Life Sciences Limited | 109.75 Million INR | -817.093% |
| Ind-Swift Limited | 946.56 Million INR | -6.333% |
| Valiant Laboratories Limited | 36.28 Million INR | -2673.595% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 88.042% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | 78.022% |
| Themis Medicare Limited | 782.85 Million INR | -28.569% |
| Hikal Limited | 2.48 Billion INR | 59.518% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 95.302% |
| Sequent Scientific Limited | 2.9 Billion INR | 65.314% |
| Novartis India Limited | 470.1 Million INR | -114.106% |
| Wockhardt Limited | 6.4 Billion INR | 84.273% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 93.036% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -6109.307% |
| Neuland Laboratories Limited | 2.92 Billion INR | 65.645% |
| Morepen Laboratories Limited | 1.98 Billion INR | 49.357% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -144.046% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -48.86% |